Treatment of mycosis fungoides/Sezary syndrome: the University of California, San Francisco (UCSF) approach.
Zackheim
Herschel S
HS
Department of Dermatology, University of California, San Francisco, California, USA. hszackheim@orca.ucsf.edu
D000287:Administration, Topical; D000328:Adult; D001707:Biopsy, Needle; D002648:Child; D002990:Clobetasol / Q000627:therapeutic use; D005260:Female; D006785:Hospitals, University; D006801:Humans; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D011701:PUVA Therapy / Q000379:methods; D017893:Photopheresis / Q000379:methods*; D011379:Prognosis; D011878:Radiotherapy / Q000379:methods*; D012495:San Francisco; D012751:Sezary Syndrome / Q000473:pathology / Q000628:therapy*; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*; D016896:Treatment Outcome; D014467:Ultraviolet Therapy / Q000379:methods
D002990:Clobetasol